Fujii M - Search Results

1

Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system.

Okochi Y, Nihashi T, Fujii M, Kato K, Okada Y, Ando Y, Maesawa S, Takebayashi S, Wakabayashi T, Naganawa S. Okochi Y, et al. Among authors: fujii m. Ann Nucl Med. 2014 Feb;28(2):94-102. doi: 10.1007/s12149-013-0787-4. Epub 2013 Nov 24. Ann Nucl Med. 2014. PMID: 24272066 Free PMC article.

2

Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes.

Yoshida J, Mizuno M, Fujii M, Kajita Y, Nakahara N, Hatano M, Saito R, Nobayashi M, Wakabayashi T. Yoshida J, et al. Among authors: fujii m. Hum Gene Ther. 2004 Jan;15(1):77-86. doi: 10.1089/10430340460732472. Hum Gene Ther. 2004. PMID: 14965379

3

Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma.

Shimato S, Natsume A, Takeuchi H, Wakabayashi T, Fujii M, Ito M, Ito S, Park IH, Bang JH, Kim SU, Yoshida J. Shimato S, et al. Among authors: fujii m. Gene Ther. 2007 Aug;14(15):1132-42. doi: 10.1038/sj.gt.3302932. Epub 2007 May 17. Gene Ther. 2007. PMID: 17508009

4

A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation.

Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, Ito M, Yoshida J. Natsume A, et al. Among authors: fujii m. Cancer Chemother Pharmacol. 2008 Apr;61(4):653-9. doi: 10.1007/s00280-007-0520-x. Epub 2007 Jun 13. Cancer Chemother Pharmacol. 2008. PMID: 17564708

5

Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report.

Ito M, Wakabayashi T, Natsume A, Hatano H, Fujii M, Yoshida J. Ito M, et al. Among authors: fujii m. Neurosurgery. 2007 Jul;61(1):E168-9; discussion E169. doi: 10.1227/01.neu.0000279739.53425.5c. Neurosurgery. 2007. PMID: 17621007

6

Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas.

Ishii D, Natsume A, Wakabayashi T, Hatano H, Asano Y, Takeuchi H, Shimato S, Ito M, Fujii M, Yoshida J. Ishii D, et al. Among authors: fujii m. Neurol Med Chir (Tokyo). 2007 Aug;47(8):341-9; discussion 350. doi: 10.2176/nmc.47.341. Neurol Med Chir (Tokyo). 2007. PMID: 17721049 Free article.

7

A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy.

Wakabayashi T, Natsume A, Hashizume Y, Fujii M, Mizuno M, Yoshida J. Wakabayashi T, et al. Among authors: fujii m. J Gene Med. 2008 Apr;10(4):329-39. doi: 10.1002/jgm.1160. J Gene Med. 2008. PMID: 18220319 Clinical Trial.

8

[Image-guided neurosurgery for brain tumor: a current perspective].

Kajita Y, Fujii M, Yoshida J, Maesawa S. Kajita Y, et al. Among authors: fujii m. No Shinkei Geka. 2008 May;36(5):443-56. No Shinkei Geka. 2008. PMID: 18516863 Review. Japanese. No abstract available.

9

p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.

Wakabayashi T, Natsume A, Hatano H, Fujii M, Shimato S, Ito M, Ohno M, Ito S, Ogura M, Yoshida J. Wakabayashi T, et al. Among authors: fujii m. Neurosurgery. 2009 Mar;64(3):455-61; discussion 461-2. doi: 10.1227/01.NEU.0000340683.19920.E3. Neurosurgery. 2009. PMID: 19240607

10

Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.

Ohno M, Natsume A, Fujii M, Ito M, Wakabayashi T. Ohno M, et al. Among authors: fujii m. Pediatr Blood Cancer. 2009 Jul;53(1):37-41. doi: 10.1002/pbc.21987. Pediatr Blood Cancer. 2009. PMID: 19260101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,703 results

Search Page

Filters